Show simple item record

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

dc.contributor.authorLisenko, Ken_US
dc.contributor.authorMcClanahan, Fen_US
dc.contributor.authorSchoening, Ten_US
dc.contributor.authorSchwarzbich, MAen_US
dc.contributor.authorCremer, Men_US
dc.contributor.authorDittrich, Ten_US
dc.contributor.authorHo, ADen_US
dc.contributor.authorWitzens-Harig, Men_US
dc.date.accessioned2016-05-10T10:53:33Z
dc.date.available2016-03-22en_US
dc.date.issued2016-04-11en_US
dc.date.submitted2016-05-09T09:46:29.276Z
dc.identifier.issn1471-2407en_US
dc.identifier.otherARTN 267en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/12244
dc.language.isoenen_US
dc.relation.ispartofBMC CANCERen_US
dc.rightsCC-BY
dc.subjectR-DHAPen_US
dc.subjectDLBCLen_US
dc.subjectRenal chemo toxicityen_US
dc.titleMinimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphomaen_US
dc.typeArticle
dc.rights.holder© 2016 Lisenko et al.
dc.identifier.doi10.1186/s12885-016-2289-yen_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000373877300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume16en_US


Files in this item

Thumbnail
Name:
Lisenko Minimal renal toxicity ...
Size:
1.037Mb
Format:
application/
View/Open

This item appears in the following Collection(s)

Show simple item record